ለውጦች

              
    

          
          
        
        

            
f
1
{
f
1
{
            
2
  "author": "Clean Ketamine Shards",
2
  "author": "Clean Ketamine Shards",
            
3
  "author_email": "inquiries.lyfeunit@proton.me",
3
  "author_email": "inquiries.lyfeunit@proton.me",
            
4
  "creator_user_id": "5ecc116b-5ec4-48f4-8366-afe5052790b1",
4
  "creator_user_id": "5ecc116b-5ec4-48f4-8366-afe5052790b1",
            
5
  "extras": [],
5
  "extras": [],
            
6
  "groups": [],
6
  "groups": [],
            
7
  "id": "a52fe06f-80fc-45f0-bc4c-580e6ca3b4c6",
7
  "id": "a52fe06f-80fc-45f0-bc4c-580e6ca3b4c6",
            
8
  "isopen": true,
8
  "isopen": true,
            
9
  "license_id": "other-at",
9
  "license_id": "other-at",
            
10
  "license_title": "Annan (Attribution)",
10
  "license_title": "Annan (Attribution)",
            
11
  "maintainer": "",
11
  "maintainer": "",
            
12
  "maintainer_email": "",
12
  "maintainer_email": "",
            
13
  "metadata_created": "2026-06-26T15:48:24.971987",
13
  "metadata_created": "2026-06-26T15:48:24.971987",
            
n
14
  "metadata_modified": "2026-06-26T15:49:53.751287",
n
14
  "metadata_modified": "2026-06-26T15:49:54.181077",
            
15
  "name": 
15
  "name": 
            
16
-99-8-pure-cas-1867-66-9-for-neuroplasticity-chronic-pain-management",
16
-99-8-pure-cas-1867-66-9-for-neuroplasticity-chronic-pain-management",
            
17
  "notes": "This dataset provides a deep dive into the technical 
17
  "notes": "This dataset provides a deep dive into the technical 
            
18
specifications and clinical potential of Clean Ketamine Shards. These 
18
specifications and clinical potential of Clean Ketamine Shards. These 
            
19
premium pharmaceutical-grade hydrochloride salt crystals (\ufffc) 
19
premium pharmaceutical-grade hydrochloride salt crystals (\ufffc) 
            
20
boast a verified 99.8% purity. Designed for the next generation of 
20
boast a verified 99.8% purity. Designed for the next generation of 
            
21
depression treatment and chronic pain management, these translucent 
21
depression treatment and chronic pain management, these translucent 
            
22
shards adhere to rigorous USP standards, ensuring unparalleled 
22
shards adhere to rigorous USP standards, ensuring unparalleled 
            
23
molecular consistency for researchers at NIASRA and the University of 
23
molecular consistency for researchers at NIASRA and the University of 
            
24
Wollongong (UOW).\r\n\r\nTechnical 
24
Wollongong (UOW).\r\n\r\nTechnical 
            
25
Specifications\r\n\t\u2022\tChemical Name: 
25
Specifications\r\n\t\u2022\tChemical Name: 
            
26
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one 
26
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one 
            
27
hydrochloride\r\n\t\u2022\tCAS Number: 
27
hydrochloride\r\n\t\u2022\tCAS Number: 
            
28
1867-66-9\r\n\t\u2022\tMolecular Weight: 274.19 
28
1867-66-9\r\n\t\u2022\tMolecular Weight: 274.19 
            
29
g/mol\r\n\t\u2022\tPurity: \u2265 99.8% (HPLC 
29
g/mol\r\n\t\u2022\tPurity: \u2265 99.8% (HPLC 
            
30
Verified)\r\n\t\u2022\tAppearance: Translucent Needular Crystalline 
30
Verified)\r\n\t\u2022\tAppearance: Translucent Needular Crystalline 
            
31
Shards\r\n\t\u2022\tSolubility: 200 mg/mL (Freely Soluble in 
31
Shards\r\n\t\u2022\tSolubility: 200 mg/mL (Freely Soluble in 
            
32
H2O)\r\n\r\nAdvanced Research 
32
H2O)\r\n\r\nAdvanced Research 
            
33
Applications\r\n\t\u2022\tNeuroplasticity & Depression: Exploring the 
33
Applications\r\n\t\u2022\tNeuroplasticity & Depression: Exploring the 
            
34
\u201cglutamate burst\u201d mechanism and mTOR pathway activation for 
34
\u201cglutamate burst\u201d mechanism and mTOR pathway activation for 
            
35
rapid synaptogenesis.\r\n\t\u2022\tChronic Pain Management: 
35
rapid synaptogenesis.\r\n\t\u2022\tChronic Pain Management: 
            
36
Investigating how high-purity shards can \u201creset\u201d 
36
Investigating how high-purity shards can \u201creset\u201d 
            
37
hyper-active pain pathways in the spinal 
37
hyper-active pain pathways in the spinal 
            
38
cord.\r\n\t\u2022\tInterventional Psychiatry: Developing precision 
38
cord.\r\n\t\u2022\tInterventional Psychiatry: Developing precision 
            
39
protocols using an optimized balance of (S)- and (R)- 
39
protocols using an optimized balance of (S)- and (R)- 
            
40
enantiomers.\r\n\t\u2022\tAnalytical Standards: Serving as a 
40
enantiomers.\r\n\t\u2022\tAnalytical Standards: Serving as a 
            
41
high-clarity reference for HPLC impurity profiling and refractive 
41
high-clarity reference for HPLC impurity profiling and refractive 
            
42
index testing.\r\n\r\nStability & Handling\r\n\t\u2022\tShelf Life: 
42
index testing.\r\n\r\nStability & Handling\r\n\t\u2022\tShelf Life: 
            
43
Exceptional stability for up to 36 months when stored in a cool, dry 
43
Exceptional stability for up to 36 months when stored in a cool, dry 
            
44
environment (20\u00b0C to 25\u00b0C).\r\n\t\u2022\tIntegrity: 
44
environment (20\u00b0C to 25\u00b0C).\r\n\t\u2022\tIntegrity: 
            
45
Vacuum-sealed and heat-shielded to preserve the delicate crystalline 
45
Vacuum-sealed and heat-shielded to preserve the delicate crystalline 
            
46
lattice during transit and storage.\r\n\t\u2022\tSafety: Best-in-class 
46
lattice during transit and storage.\r\n\t\u2022\tSafety: Best-in-class 
            
47
handling protocols within controlled laboratory environments to 
47
handling protocols within controlled laboratory environments to 
            
48
maintain strict USP monograph standards.\r\n\r\nSource 
48
maintain strict USP monograph standards.\r\n\r\nSource 
            
49
Information\r\nFor comprehensive technical data and professional-grade 
49
Information\r\nFor comprehensive technical data and professional-grade 
            
50
procurement, 
50
procurement, 
            
51
visit:\r\nhttps://lyfeunit.com/product/order-clean-ketamine-shards/",
51
visit:\r\nhttps://lyfeunit.com/product/order-clean-ketamine-shards/",
            
52
  "num_resources": 1,
52
  "num_resources": 1,
            
53
  "num_tags": 15,
53
  "num_tags": 15,
            
54
  "organization": null,
54
  "organization": null,
            
55
  "owner_org": null,
55
  "owner_org": null,
            
56
  "private": false,
56
  "private": false,
            
57
  "relationships_as_object": [],
57
  "relationships_as_object": [],
            
58
  "relationships_as_subject": [],
58
  "relationships_as_subject": [],
            
59
  "resources": [
59
  "resources": [
            
60
    {
60
    {
            
61
      "cache_last_updated": null,
61
      "cache_last_updated": null,
            
62
      "cache_url": null,
62
      "cache_url": null,
            
63
      "created": "2026-06-26T15:49:53.776052",
63
      "created": "2026-06-26T15:49:53.776052",
            
64
      "datastore_active": false,
64
      "datastore_active": false,
            
65
      "description": "This dataset captures the essence of high-level 
65
      "description": "This dataset captures the essence of high-level 
            
66
chemical synthesis, offering a robust foundation for studying Clean 
66
chemical synthesis, offering a robust foundation for studying Clean 
            
67
Ketamine Shards (CAS 1867-66-9). With a purity threshold of 99.8%, 
67
Ketamine Shards (CAS 1867-66-9). With a purity threshold of 99.8%, 
            
68
these shards are meticulously refined to eliminate unreacted 
68
these shards are meticulously refined to eliminate unreacted 
            
69
precursors and heavy metal contaminants. This ensures that every data 
69
precursors and heavy metal contaminants. This ensures that every data 
            
70
point remains accurate and reliable, meeting the sophisticated 
70
point remains accurate and reliable, meeting the sophisticated 
            
71
analytical needs of the National Institute for Applied Statistics 
71
analytical needs of the National Institute for Applied Statistics 
            
72
Research Australia (NIASRA) and the University of Wollongong 
72
Research Australia (NIASRA) and the University of Wollongong 
            
73
(UOW).\r\n\r\nClinical & Technical Significance\r\nThe data provided 
73
(UOW).\r\n\r\nClinical & Technical Significance\r\nThe data provided 
            
74
here drives innovation in:\r\n\r\n\t\u2022\tSynaptogenesis Research: 
74
here drives innovation in:\r\n\r\n\t\u2022\tSynaptogenesis Research: 
            
75
Unlocking new insights into how mental health interventions can 
75
Unlocking new insights into how mental health interventions can 
            
76
trigger the growth of new neural connections.\r\n\t\u2022\tPain 
76
trigger the growth of new neural connections.\r\n\t\u2022\tPain 
            
77
Pathway Modulation: Analyzing the power of high-purity crystalline 
77
Pathway Modulation: Analyzing the power of high-purity crystalline 
            
78
structures to silence chronic pain signals.\r\n\t\u2022\tMolecular 
78
structures to silence chronic pain signals.\r\n\t\u2022\tMolecular 
            
79
Consistency: Setting a benchmark for predictable therapeutic potency 
79
Consistency: Setting a benchmark for predictable therapeutic potency 
            
80
through strict adherence to USP monographs.\r\n",
80
through strict adherence to USP monographs.\r\n",
            
81
      "format": "",
81
      "format": "",
            
82
      "hash": "",
82
      "hash": "",
            
83
      "id": "32d6a563-b9af-46ff-984f-6e06e23791ad",
83
      "id": "32d6a563-b9af-46ff-984f-6e06e23791ad",
            
84
      "last_modified": "2026-06-26T15:49:53.746632",
84
      "last_modified": "2026-06-26T15:49:53.746632",
            
n
85
      "metadata_modified": "2026-06-26T15:49:53.758461",
n
85
      "metadata_modified": "2026-06-26T15:49:54.184399",
            
86
      "mimetype": null,
86
      "mimetype": null,
            
87
      "mimetype_inner": null,
87
      "mimetype_inner": null,
            
88
      "name": "Clean Ketamine Shards 99.8% Pure (CAS 1867-66-9) 
88
      "name": "Clean Ketamine Shards 99.8% Pure (CAS 1867-66-9) 
            
89
Research Data",
89
Research Data",
            
90
      "package_id": "a52fe06f-80fc-45f0-bc4c-580e6ca3b4c6",
90
      "package_id": "a52fe06f-80fc-45f0-bc4c-580e6ca3b4c6",
            
91
      "position": 0,
91
      "position": 0,
            
92
      "resource_type": null,
92
      "resource_type": null,
            
93
      "size": 70650,
93
      "size": 70650,
            
94
      "state": "active",
94
      "state": "active",
            
95
      "url": 
95
      "url": 
            
96
b9af-46ff-984f-6e06e23791ad/download/clean-ketamine-shards.jpeg.webp",
96
b9af-46ff-984f-6e06e23791ad/download/clean-ketamine-shards.jpeg.webp",
            
97
      "url_type": "upload"
97
      "url_type": "upload"
            
98
    }
98
    }
            
99
  ],
99
  ],
            
t
100
  "state": "draft",
t
100
  "state": "active",
            
101
  "tags": [
101
  "tags": [
            
102
    {
102
    {
            
103
      "display_name": "CAS 1867-66-9",
103
      "display_name": "CAS 1867-66-9",
            
104
      "id": "65e9d7bb-2917-42c6-a6e5-363a9c0c7b0c",
104
      "id": "65e9d7bb-2917-42c6-a6e5-363a9c0c7b0c",
            
105
      "name": "CAS 1867-66-9",
105
      "name": "CAS 1867-66-9",
            
106
      "state": "active",
106
      "state": "active",
            
107
      "vocabulary_id": null
107
      "vocabulary_id": null
            
108
    },
108
    },
            
109
    {
109
    {
            
110
      "display_name": "Chronic Pain Management",
110
      "display_name": "Chronic Pain Management",
            
111
      "id": "9491f3ee-5692-4134-9635-d5093de378ac",
111
      "id": "9491f3ee-5692-4134-9635-d5093de378ac",
            
112
      "name": "Chronic Pain Management",
112
      "name": "Chronic Pain Management",
            
113
      "state": "active",
113
      "state": "active",
            
114
      "vocabulary_id": null
114
      "vocabulary_id": null
            
115
    },
115
    },
            
116
    {
116
    {
            
117
      "display_name": "Clean Ketamine Shards",
117
      "display_name": "Clean Ketamine Shards",
            
118
      "id": "6e44c011-b56c-429d-af07-2bb101a0a6f8",
118
      "id": "6e44c011-b56c-429d-af07-2bb101a0a6f8",
            
119
      "name": "Clean Ketamine Shards",
119
      "name": "Clean Ketamine Shards",
            
120
      "state": "active",
120
      "state": "active",
            
121
      "vocabulary_id": null
121
      "vocabulary_id": null
            
122
    },
122
    },
            
123
    {
123
    {
            
124
      "display_name": "Data",
124
      "display_name": "Data",
            
125
      "id": "e0872c47-a8dc-4845-9d19-7cf661eb6120",
125
      "id": "e0872c47-a8dc-4845-9d19-7cf661eb6120",
            
126
      "name": "Data",
126
      "name": "Data",
            
127
      "state": "active",
127
      "state": "active",
            
128
      "vocabulary_id": null
128
      "vocabulary_id": null
            
129
    },
129
    },
            
130
    {
130
    {
            
131
      "display_name": "Depression Treatment",
131
      "display_name": "Depression Treatment",
            
132
      "id": "c73f69b8-c749-45dd-b793-cd83244e5f44",
132
      "id": "c73f69b8-c749-45dd-b793-cd83244e5f44",
            
133
      "name": "Depression Treatment",
133
      "name": "Depression Treatment",
            
134
      "state": "active",
134
      "state": "active",
            
135
      "vocabulary_id": null
135
      "vocabulary_id": null
            
136
    },
136
    },
            
137
    {
137
    {
            
138
      "display_name": "HPLC Verified",
138
      "display_name": "HPLC Verified",
            
139
      "id": "950b000e-6aa9-4281-9b0d-fdbb5de15342",
139
      "id": "950b000e-6aa9-4281-9b0d-fdbb5de15342",
            
140
      "name": "HPLC Verified",
140
      "name": "HPLC Verified",
            
141
      "state": "active",
141
      "state": "active",
            
142
      "vocabulary_id": null
142
      "vocabulary_id": null
            
143
    },
143
    },
            
144
    {
144
    {
            
145
      "display_name": "Ketamine Shards",
145
      "display_name": "Ketamine Shards",
            
146
      "id": "cab7d1ab-44c2-47bc-a154-6e58a99bf5cf",
146
      "id": "cab7d1ab-44c2-47bc-a154-6e58a99bf5cf",
            
147
      "name": "Ketamine Shards",
147
      "name": "Ketamine Shards",
            
148
      "state": "active",
148
      "state": "active",
            
149
      "vocabulary_id": null
149
      "vocabulary_id": null
            
150
    },
150
    },
            
151
    {
151
    {
            
152
      "display_name": "NIASRA",
152
      "display_name": "NIASRA",
            
153
      "id": "1b4af2e3-493f-4ee9-bfbc-30d31a49f0bf",
153
      "id": "1b4af2e3-493f-4ee9-bfbc-30d31a49f0bf",
            
154
      "name": "NIASRA",
154
      "name": "NIASRA",
            
155
      "state": "active",
155
      "state": "active",
            
156
      "vocabulary_id": null
156
      "vocabulary_id": null
            
157
    },
157
    },
            
158
    {
158
    {
            
159
      "display_name": "NMDA Antagonist",
159
      "display_name": "NMDA Antagonist",
            
160
      "id": "a63f032f-29d9-4d47-9122-7161fecfb948",
160
      "id": "a63f032f-29d9-4d47-9122-7161fecfb948",
            
161
      "name": "NMDA Antagonist",
161
      "name": "NMDA Antagonist",
            
162
      "state": "active",
162
      "state": "active",
            
163
      "vocabulary_id": null
163
      "vocabulary_id": null
            
164
    },
164
    },
            
165
    {
165
    {
            
166
      "display_name": "Neuroplasticity",
166
      "display_name": "Neuroplasticity",
            
167
      "id": "10d587ec-b7b0-42f0-813f-44faf92d46ca",
167
      "id": "10d587ec-b7b0-42f0-813f-44faf92d46ca",
            
168
      "name": "Neuroplasticity",
168
      "name": "Neuroplasticity",
            
169
      "state": "active",
169
      "state": "active",
            
170
      "vocabulary_id": null
170
      "vocabulary_id": null
            
171
    },
171
    },
            
172
    {
172
    {
            
173
      "display_name": "Pharmaceutical Grade",
173
      "display_name": "Pharmaceutical Grade",
            
174
      "id": "184bad88-3411-45d7-957e-11a377623017",
174
      "id": "184bad88-3411-45d7-957e-11a377623017",
            
175
      "name": "Pharmaceutical Grade",
175
      "name": "Pharmaceutical Grade",
            
176
      "state": "active",
176
      "state": "active",
            
177
      "vocabulary_id": null
177
      "vocabulary_id": null
            
178
    },
178
    },
            
179
    {
179
    {
            
180
      "display_name": "Pharmacology",
180
      "display_name": "Pharmacology",
            
181
      "id": "7b8a5e22-8b54-44a8-97e6-0fb830dde386",
181
      "id": "7b8a5e22-8b54-44a8-97e6-0fb830dde386",
            
182
      "name": "Pharmacology",
182
      "name": "Pharmacology",
            
183
      "state": "active",
183
      "state": "active",
            
184
      "vocabulary_id": null
184
      "vocabulary_id": null
            
185
    },
185
    },
            
186
    {
186
    {
            
187
      "display_name": "Synaptogenesis",
187
      "display_name": "Synaptogenesis",
            
188
      "id": "cc4b069d-294a-49bd-93c2-b8a4f660ab6c",
188
      "id": "cc4b069d-294a-49bd-93c2-b8a4f660ab6c",
            
189
      "name": "Synaptogenesis",
189
      "name": "Synaptogenesis",
            
190
      "state": "active",
190
      "state": "active",
            
191
      "vocabulary_id": null
191
      "vocabulary_id": null
            
192
    },
192
    },
            
193
    {
193
    {
            
194
      "display_name": "UOW",
194
      "display_name": "UOW",
            
195
      "id": "db7fb5f3-4f8e-45eb-ac60-18d37318f122",
195
      "id": "db7fb5f3-4f8e-45eb-ac60-18d37318f122",
            
196
      "name": "UOW",
196
      "name": "UOW",
            
197
      "state": "active",
197
      "state": "active",
            
198
      "vocabulary_id": null
198
      "vocabulary_id": null
            
199
    },
199
    },
            
200
    {
200
    {
            
201
      "display_name": "USP Standards",
201
      "display_name": "USP Standards",
            
202
      "id": "2be5de89-e2da-45ff-929d-fe49a896c539",
202
      "id": "2be5de89-e2da-45ff-929d-fe49a896c539",
            
203
      "name": "USP Standards",
203
      "name": "USP Standards",
            
204
      "state": "active",
204
      "state": "active",
            
205
      "vocabulary_id": null
205
      "vocabulary_id": null
            
206
    }
206
    }
            
207
  ],
207
  ],
            
208
  "title": "Clean Ketamine Shards 99.8% Pure (CAS 1867-66-9) for 
208
  "title": "Clean Ketamine Shards 99.8% Pure (CAS 1867-66-9) for 
            
209
Neuroplasticity & Chronic Pain Management",
209
Neuroplasticity & Chronic Pain Management",
            
210
  "type": "dataset",
210
  "type": "dataset",
            
211
  "url": "https://lyfeunit.com/product/order-clean-ketamine-shards/",
211
  "url": "https://lyfeunit.com/product/order-clean-ketamine-shards/",
            
212
  "version": "1.0"
212
  "version": "1.0"
            
213
}
213
}